Palatin Technologies
PTN
#9923
Rang
€33.63 M
Capitalisation boursière
19,75 €
Prix de l'action
4.59%
Changement (1 jour)
2,148.55%
Changement (1 an)

Palatin Technologies (PTN) - Dette totale

Dette totale au bilan au Mars 2025 : 0.22 Million d'euros

Selon les derniers rapports financiers de Palatin Technologies, la dette totale de l'entreprise est de 0.22 Million d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Palatin Technologies - Dette totale au bilan (de 1997 à 2025)

Dette totale par année

Année Dette totale Changement
2024-06-30€0.54 M-42.88%
2023-06-30€0.96 M-12.58%
2022-06-30€1.1 M4.26%
2021-06-30€1.05 M-6.27%
2020-06-30€1.12 M284.7%
2019-06-30€0.29 M-94.54%
2018-06-30€5.36 M-56.63%
2017-06-30€12.37 M-29.6%
2016-06-30€17.57 M98.75%
2015-06-30€8.84 M
2014-06-30N/A-100%
2013-06-30€0.01 M-54.1%
2012-06-30€0.03 M-37.34%
2011-06-30€0.05 M95.93%
2010-06-30€0.02 M-68.44%
2009-06-30€0.08 M-64.8%
2008-06-30€0.24 M-33.25%
2007-06-30€0.36 M46.65%
2006-06-30€0.24 M886.38%
2005-06-30€0.02 M-51.68%
2004-06-30€0.05 M-77.35%
2003-06-30€0.23 M
2001-06-30€0.03 M
1999-06-30€1.94 M156.09%
1998-06-30€0.75 M-50%
1997-06-30€1.51 M-44.71%
1996-06-30€2.74 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
MediciNova
MNOV
€0.25 M 15.12%🇺🇸 USA
GlycoMimetics
GLYC
N/AN/A🇺🇸 USA
Neurocrine Biosciences
NBIX
€0.36 Md 163,274.27%🇺🇸 USA
ANI Pharmaceuticals
ANIP
€0.53 Md 236,460.90%🇺🇸 USA
Ligand Pharmaceuticals
LGND
€0.38 Md 171,891.84%🇺🇸 USA
Dicerna Pharmaceuticals
DRNA
N/AN/A🇺🇸 USA
Johnson & Johnson
JNJ
€39.33 Md 17,464,242.92%🇺🇸 USA
Ardelyx
ARDX
€0.17 Md 79,074.36%🇺🇸 USA
AstraZeneca
AZN
€28.02 Md 12,444,412.24%🇬🇧 UK